Welcome!

News Feed Item

Study Shows Pycnogenol® Improves Fitness And Muscle Recovery

Supplementation with renowned pine bark extract shown effective in boosting muscle performance, increasing endurance and reducing cramping by controlling oxidative stress

HOBOKEN, N.J., Jan. 15, 2014 /PRNewswire/ -- New research published in the December 2013 issue of The Journal of Sports Medicine and Physical Fitness shows the effectiveness of a natural supplement in improving overall fitness performance levels and recovery. A clinical trial found that Pycnogenol® (pic-noj-en-ol), an antioxidant from French maritime pine tree bark, is effective in improving performance and endurance and reducing muscle cramping and soreness by controlling oxidative stress – an imbalance between antioxidants and pro-oxidants in favor of the latter that can hinder the body's ability to repair muscle damage.

(Logo: http://photos.prnewswire.com/prnh/20120607/MM20529-a)

"Both recreational and serious athletes feel the effects of muscle fatigue, cramping and soreness from oxidative stress – these factors can impact fitness performance and recovery. Those starting a fitness program, perhaps as part of a New Year resolution to get in shape, may experience pain or soreness that keeps them from getting into their new routine. The findings in this study show that supplementation with Pycnogenol® can encourage performance, boost recovery and help with achieving desired fitness results," said Steven Lamm M.D. expert and practitioner in health and nutritional medicine.

The Pycnogenol® study was based on the Army Physical Fitness Test (APFT) which evaluates physical fitness levels through muscular strength, endurance and cardiovascular performance. Basic metrics of the APFT were applied in this research, including the number of sit-ups and push-ups a participant can complete in two minutes and the time it takes to run two miles.

Conducted in two parts at the Chieti-Pescara University in Pescara, Italy, the study followed 201 subjects ages 32-36 years old, who were each tested using either APFT standards or tracked while completing an average 100-minute triathlon.

Each of the clinical trials was divided into two groups: one group of participants that supplemented their daily routine with Pycnogenol® and one group that did not. The results of both distinct trials found over four to eight weeks of daily supplementation with Pycnogenol®, the participants significantly increased their level of physical fitness and endurance and also reduced training-induced muscular pain and oxidative stress.

Part One of the study consisted of 147 recreational athletes. Each of the 74 participants in the Pycnogenol® group (38 males; 36 females) incorporated 100 mg of Pycnogenol® into their daily routine; the remaining 73 (36 males; 37 females) did not. All participants were tested on the APFT metrics. Those in the Pycnogenol® group showed remarkable improvements in all areas within eight weeks, including: 

  • Two mile run finish time significantly decreased by an average of nearly two minutes
  • Two minute push-up endurance significantly increased an average of 25 percent
  • Two minute sit-up endurance significantly increased an average of 15 percent

Part Two of the study examined an even higher level of fitness, testing 54 male triathletes. The Pycnogenol® group included 32 participants who incorporated 150 mg of Pycnogenol® into their daily routine; the control group was comprised of 22 who did not. Participants were tracked over four weeks and evaluated by an average 100-minute triathlon consisting of a .47 mile swim, 12 mile bike ride and 5k run. Those participants who supplemented with Pycnogenol® shed significant time off their splits and reduced oxidative stress levels. Those who supplemented their diet and exercise routine with daily use of Pycnogenol® for 30 days:

  • Significantly increased speed and strength (100 minute triathlon time: 1:40:24 to 1:29:44)
  • Significantly reduced muscular cramping
  • Controlled oxidative stress

Study participants were followed between four and eight weeks. Subjects tested in Part One of the study completed the APFT five times within one week and subjects in Part Two completed the triathlon 10 times within 30 days. Throughout the study, participants completed routine blood tests to exclude any risked condition and were evaluated on their level of oxidative stress. At no time was the participant's activity or working conditions changed, limited or altered.

"This study provides evidence that daily supplementation of Pycnogenol® offers a natural approach to help reduce post-workout muscular pain, increase levels of physical performance and get you training again sooner," said Dr. Gianni Belcaro, lead researcher of the study.  "Pycnogenol®, along with good training and proper nutrition, may help to significantly improve physical fitness and reduce oxidative stress and muscular pain in both in those who exercise recreationally and triathletes."

This new research adds to the catalog of sports nutrition research on Pycnogenol® and reinforces previous findings that the natural extract helps to strengthen blood vessels, alleviate muscular pain and enhance sports endurance. To review the clinical research and additional information on Pycnogenol®, visit www.Pycnogenol.com.

About Pycnogenol®
Pycnogenol® is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, bioflavonoids and organic acids, which offer extensive natural health benefits.  The extract has been widely studied for the past 40 years and has more than 340 published studies and review articles ensuring safety and efficacy as an ingredient.  Today, Pycnogenol® is available in more than 700 dietary supplements, multi-vitamins and health products worldwide.  For more information, visit www.pycnogenol.com.

About Horphag Research (USA) Inc.
Horphag Research (USA) Inc., based in Hoboken, New Jersey, is the North American distributor for Pycnogenol® (pic-noj-en-all) brand French maritime pine bark extract on behalf of Horphag Research. Pycnogenol® is a registered trademark of Horphag Research Ltd. For its patented ingredient, Pycnogenol®, Horphag Research has been awarded the Frost & Sullivan Excellence in Research Award, Nutraceutical Business & Technology Safety & Quality Award, SupplySide West Scientific Excellence Award and The American Botanical Council's Tyler Research Award.  Horphag Research (USA) has the exclusive rights to market and sell Pycnogenol® in North America and benefits from more than 40 years of scientific research assuring the safety and efficacy of Pycnogenol® as a dietary supplement.  For more information about Pycnogenol® visit www.pycnogenol.com.

Krissy Zotaley
312-981-8553
kzotaley@mww.com

SOURCE Horphag Research (USA) Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settle...
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
In his general session at 18th Cloud Expo, Lee Atchison, Principal Cloud Architect and Advocate at New Relic, discussed cloud as a ‘better data center’ and how it adds new capacity (faster) and improves application availability (redundancy). The cloud is a ‘Dynamic Tool for Dynamic Apps’ and resource allocation is an integral part of your application architecture, so use only the resources you need and allocate /de-allocate resources on the fly.
Containers have changed the mind of IT in DevOps. They enable developers to work with dev, test, stage and production environments identically. Containers provide the right abstraction for microservices and many cloud platforms have integrated them into deployment pipelines. DevOps and Containers together help companies to achieve their business goals faster and more effectively. In his session at DevOps Summit, Ruslan Synytsky, CEO and Co-founder of Jelastic, reviewed the current landscape of D...
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
SYS-CON Events announced today that Outlyer, a monitoring service for DevOps and operations teams, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Outlyer is a monitoring service for DevOps and Operations teams running Cloud, SaaS, Microservices and IoT deployments. Designed for today's dynamic environments that need beyond cloud-scale monitoring, we make monitoring effortless so you...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo 2017. The @DevOpsSummit at Cloud Expo New York will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and @DevOpsSummit at Cloud Expo Silicon Valley will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain.
Column Technologies exhibited at SYS-CON's @DevOpsSummit at Cloud Expo, which took place at the Javits Center in New York City, NY, in June 2016. Established in 1998, Column Technologies is a global technology solutions provider with over 400 employees, headquartered in the United States with offices in Canada, India, and the United Kingdom. Column Technologies provides “Best of Breed” technology solutions that automate the key DevOps principals and help our customers meet today’s DevOps and Dig...
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend @CloudExpo | @ThingsExpo, June 6-8, 2017, at the Javits Center in New York City, NY and October 31 - November 2, 2017, Santa Clara Convention Center, CA. Learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.